
Check-Cap Ltd. CHEK
€ 1.18
-2.16%
Geschäftsbericht 2024
hinzugefügt 25.10.2025
Check-Cap Ltd. Betriebsaufwand 2011-2025 | CHEK
Betriebsaufwand Jährlich Check-Cap Ltd.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 14.1 M | 11.1 M | 10 M | 9.06 M | 12.5 M | 4.81 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.1 M | 4.81 M | 10.2 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | $ 0.33 | -6.23 % | $ 30.6 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | $ 3.75 | 1.08 % | $ 308 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | $ 2.99 | - | $ 399 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | $ 21.99 | - | $ 562 M | ||
|
Genetron Holdings Limited
GTH
|
983 M | $ 4.03 | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | $ 0.46 | 0.22 % | $ 16.8 M | ||
|
Pacific Biosciences of California
PACB
|
387 M | $ 2.23 | -4.91 % | $ 566 M | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.4 | 0.31 % | $ 20 B | ||
|
Meridian Bioscience
VIVO
|
134 M | $ 33.97 | - | $ 1.49 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | $ 0.48 | -20.0 % | $ 1.06 M | ||
|
Quidel Corporation
QDEL
|
285 M | $ 27.64 | 2.39 % | $ 1.16 B | ||
|
Quotient Limited
QTNT
|
106 M | $ 0.32 | -11.32 % | $ 1.1 M | ||
|
Bioventus
BVS
|
217 M | $ 6.58 | 0.38 % | $ 412 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | $ 165.21 | - | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 564.29 | -0.48 % | $ 216 B | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 31.45 | -4.38 % | $ 1.82 B | ||
|
Heska Corporation
HSKA
|
131 M | $ 119.99 | - | $ 1.31 B | ||
|
Motus GI Holdings
MOTS
|
18.6 M | $ 0.17 | -34.28 % | $ 263 K | ||
|
Biocept
BIOC
|
21.6 M | $ 0.43 | -13.05 % | $ 7.29 M | ||
|
Syneos Health
SYNH
|
4.12 B | $ 42.98 | - | $ 4.46 B | ||
|
Invitae Corporation
NVTA
|
343 M | $ 0.09 | - | $ 21.2 M | ||
|
DermTech
DMTK
|
104 M | $ 0.09 | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
778 M | $ 0.29 | -17.87 % | $ 25.9 M | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 25.99 | 1.9 % | $ 722 M | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 13.51 | -3.43 % | $ 383 M | ||
|
Exagen
XGN
|
40.6 M | $ 11.86 | 1.63 % | $ 210 M | ||
|
PerkinElmer
PKI
|
1.07 B | $ 115.24 | -0.91 % | $ 14.7 B | ||
|
OpGen
OPGN
|
21.9 M | $ 1.96 | -16.95 % | $ 1.54 M | ||
|
DexCom
DXCM
|
1.69 B | $ 59.78 | 2.68 % | $ 23.1 B | ||
|
Organovo Holdings
ONVO
|
23.3 M | $ 2.12 | -2.3 % | $ 19.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 12.18 | -9.51 % | $ 131 M | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 214.2 | -0.55 % | $ 157 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 6.26 | 1.46 % | $ 1.36 B | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.71 | -0.52 % | $ 6.23 M | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 22.96 | 2.25 % | $ 694 M | ||
|
Psychemedics Corporation
PMD
|
11.3 M | $ 2.67 | -1.84 % | $ 15.3 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | $ 0.77 | - | $ 7.1 B | ||
|
Myriad Genetics
MYGN
|
709 M | $ 8.03 | -0.19 % | $ 728 M | ||
|
Renalytix AI plc
RNLX
|
29.8 M | $ 0.21 | 5.66 % | $ 22.7 M | ||
|
Medpace Holdings
MEDP
|
118 M | $ 596.13 | 1.92 % | $ 18.5 B | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 214.25 | -1.05 % | $ 38.8 B | ||
|
CareDx, Inc
CDNA
|
484 M | $ 14.61 | -2.6 % | $ 786 M | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 17.58 | 4.3 % | $ 99.4 M | ||
|
Biodesix
BDSX
|
106 M | $ 6.33 | -7.3 % | $ 821 M | ||
|
T2 Biosystems
TTOO
|
38.2 M | $ 0.12 | -39.35 % | $ 313 K | ||
|
OPKO Health
OPK
|
217 M | $ 1.42 | 4.04 % | $ 986 M | ||
|
Guardant Health
GH
|
226 M | $ 98.46 | 5.84 % | $ 12.1 B | ||
|
Agilent Technologies
A
|
1.99 B | $ 144.14 | -1.5 % | $ 43.8 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 1.0 | - | $ 61.9 M | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 0.41 | -10.11 % | $ 12 M |